Below is a detailed analysis of the quarterly data for Anupam Rasayan India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 500.00 Cr.. The value appears strong and on an upward trend. It has increased from 390.00 Cr. (Dec 2024) to 500.00 Cr., marking an increase of 110.00 Cr..
For Expenses, as of Mar 2025, the value is 356.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 266.00 Cr. (Dec 2024) to 356.00 Cr., marking an increase of 90.00 Cr..
For Operating Profit, as of Mar 2025, the value is 144.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Dec 2024) to 144.00 Cr., marking an increase of 20.00 Cr..
For OPM %, as of Mar 2025, the value is 29.00%. The value appears to be declining and may need further review. It has decreased from 32.00% (Dec 2024) to 29.00%, marking a decrease of 3.00%.
For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 10.00 Cr..
For Interest, as of Mar 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.00 Cr. (Dec 2024) to 31.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Dec 2024) to 31.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is 88.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Dec 2024) to 88.00 Cr., marking an increase of 29.00 Cr..
For Tax %, as of Mar 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 9.00% (Dec 2024) to 29.00%, marking an increase of 20.00%.
For Net Profit, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Dec 2024) to 63.00 Cr., marking an increase of 9.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 4.05. The value appears strong and on an upward trend. It has increased from 2.56 (Dec 2024) to 4.05, marking an increase of 1.49.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:58 pm
Metric
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
502
529
811
1,074
1,602
1,475
1,437
Expenses
408
394
617
769
1,171
1,094
1,036
Operating Profit
93
135
194
305
431
381
401
OPM %
19%
25%
24%
28%
27%
26%
28%
Other Income
19
11
26
8
10
30
11
Interest
24
45
69
31
63
89
112
Depreciation
23
29
52
60
71
80
102
Profit before tax
66
72
100
222
308
242
198
Tax %
24%
26%
30%
31%
30%
31%
19%
Net Profit
49
53
70
152
217
167
160
EPS in Rs
9.85
10.64
7.04
15.18
16.84
11.72
8.49
Dividend Payout %
0%
0%
7%
7%
15%
11%
0%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
8.16%
32.08%
117.14%
42.76%
-23.04%
-4.19%
Change in YoY Net Profit Growth (%)
0.00%
23.91%
85.07%
-74.38%
-65.80%
18.85%
Anupam Rasayan India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
%
5 Years:
22%
3 Years:
10%
TTM:
-3%
Compounded Profit Growth
10 Years:
%
5 Years:
12%
3 Years:
-15%
TTM:
-26%
Stock Price CAGR
10 Years:
%
5 Years:
%
3 Years:
22%
1 Year:
48%
Return on Equity
10 Years:
%
5 Years:
6%
3 Years:
5%
Last Year:
3%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Anupam Rasayan India Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.48 (Mar 24) to 8.50, marking a decrease of 6.98.
For Diluted EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.46 (Mar 24) to 8.50, marking a decrease of 6.96.
For Cash EPS (Rs.), as of Mar 25, the value is 23.86. This value is within the healthy range. It has increased from 22.51 (Mar 24) to 23.86, marking an increase of 1.35.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 130.72. It has decreased from 134.36 (Mar 24) to 130.72, marking a decrease of 3.64.
For PBDIT / Share (Rs.), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 37.43 (Mar 24) to 37.51, marking an increase of 0.08.
For PBIT / Share (Rs.), as of Mar 25, the value is 28.20. This value is within the healthy range. It has decreased from 30.17 (Mar 24) to 28.20, marking a decrease of 1.97.
For PBT / Share (Rs.), as of Mar 25, the value is 18.00. This value is within the healthy range. It has decreased from 22.02 (Mar 24) to 18.00, marking a decrease of 4.02.
For Net Profit / Share (Rs.), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.25 (Mar 24) to 14.55, marking a decrease of 0.70.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has decreased from 11.71 (Mar 24) to 8.49, marking a decrease of 3.22.
For PBDIT Margin (%), as of Mar 25, the value is 28.69. This value is within the healthy range. It has increased from 27.85 (Mar 24) to 28.69, marking an increase of 0.84.
For PBIT Margin (%), as of Mar 25, the value is 21.57. This value exceeds the healthy maximum of 20. It has decreased from 22.45 (Mar 24) to 21.57, marking a decrease of 0.88.
For PBT Margin (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has decreased from 16.39 (Mar 24) to 13.76, marking a decrease of 2.63.
For Net Profit Margin (%), as of Mar 25, the value is 11.13. This value exceeds the healthy maximum of 10. It has decreased from 11.35 (Mar 24) to 11.13, marking a decrease of 0.22.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 8. It has decreased from 8.71 (Mar 24) to 6.49, marking a decrease of 2.22.
For Return on Networth / Equity (%), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 15. It has decreased from 4.65 (Mar 24) to 3.27, marking a decrease of 1.38.
For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has decreased from 10.07 (Mar 24) to 8.95, marking a decrease of 1.12.
For Return On Assets (%), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.36 (Mar 24) to 0.46, marking an increase of 0.10.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.35 (Mar 24) to 0.29, marking a decrease of 0.06.
For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 1.69 (Mar 24) to 1.42, marking a decrease of 0.27.
For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.62, marking a decrease of 0.27.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 4. It has increased from 0.69 (Mar 24) to 0.74, marking an increase of 0.05.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.71 (Mar 24) to 0.00, marking a decrease of 16.71.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.32 (Mar 24) to 0.00, marking a decrease of 10.32.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.29 (Mar 24) to 0.00, marking a decrease of 83.29.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.68 (Mar 24) to 0.00, marking a decrease of 89.68.
For Interest Coverage Ratio (X), as of Mar 25, the value is 3.67. This value is within the healthy range. It has decreased from 4.59 (Mar 24) to 3.67, marking a decrease of 0.92.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.87 (Mar 24) to 2.43, marking a decrease of 0.44.
For Enterprise Value (Cr.), as of Mar 25, the value is 9,804.24. It has decreased from 10,438.77 (Mar 24) to 9,804.24, marking a decrease of 634.53.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.82. This value exceeds the healthy maximum of 3. It has decreased from 7.08 (Mar 24) to 6.82, marking a decrease of 0.26.
For EV / EBITDA (X), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 15. It has decreased from 25.40 (Mar 24) to 23.78, marking a decrease of 1.62.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 83.28 (Mar 24) to 0.00, marking a decrease of 83.28.
For Price / BV (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.94, marking a decrease of 0.51.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Anupam Rasayan India Ltd as of June 30, 2025 is: 918.68
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 30, 2025, Anupam Rasayan India Ltd is Overvalued by 18.70% compared to the current share price 1,130.00
Intrinsic Value of Anupam Rasayan India Ltd as of June 30, 2025 is: 953.74
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 30, 2025, Anupam Rasayan India Ltd is Overvalued by 15.60% compared to the current share price 1,130.00
Last 5 Year EPS CAGR: 3.82%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Anupam Rasayan India Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 3.27% (Industry Average ROE: 25.24%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 133 (Industry average Stock P/E: 52.84)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.46
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Anupam Rasayan India Ltd. is a Public Limited Listed company incorporated on 30/09/2003 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ2003PLC042988 and registration number is 042988. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 895.90 Cr. and Equity Capital is Rs. 109.93 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Chemicals - Speciality - Others
1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Surat Gujarat 395007
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Anupam Rasayan India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
